How Ads Increase Your Credit Card Bills
A new Federal Reserve study shows credit cards' high interest rates aren't because of lending risk — they reflect monopoly power built by marketing campaigns.
Business
Critical coverage on the global financial system and domestic policies that shape the U.S. economy, with a focus on corporate wrongdoing.
Musk Has Triggered A Corporate Deregulation Bomb
A Delaware bill would award Elon Musk $56 billion, shield corporate executives from liability, and strip away voting power from shareholders.
Are Hopeful Parents Victims Of A Fertility Scam?
Genetic tests promised parents healthy pregnancies. New class action lawsuits say they may be worthless.
You’ve Already Paid $6 Billion For Weight-Loss Drugs You Can’t Afford
U.S. taxpayers spent billions developing Ozempic-type diabetes and weight-loss drugs — now those drugs’ markups could bankrupt the U.S. health care system.
The Billion-Dollar Taxpayer Math Behind The Ozempic Boom
How Americans spent $6.2 billion to develop overpriced diabetes and weight-loss drugs.
The Looting Of America’s Affordable Housing Fund
Private equity firms are diverting billions from a Great Depression-era mortgage program — and making huge profits.
The Devil In Your Cereal Bowl
Why a controversial chemical is tainting your foods — and what you can do to protect yourself.
The Plan To Make America Hazardous Again
Trump’s EPA could stop states from warning people about potentially dangerous chemicals sprayed on their food.
YOU LOVE TO SEE IT: Microplastics Meet Their Match
Your fruit bowl comes to the rescue, traffic tax hits the jackpot, anti-abortion activists get buffered, and the Granite State goes green.
The Red State Workers Caught In Trump’s EV Battle
Many clean energy boom towns voted for Trump. Will his administration put them at risk?